A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
Clinical trial NCT07656727 · RECRUITING
Trial details
- NCT number
- NCT07656727
- Sponsor
- BioAge Labs, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-11
- Primary completion
- 2026-11-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.